Memantine for prophylaxis of chronic tension-type headache--a double-blind, randomized, crossover clinical trial

Keyphrases

• Chronic Tension-type Headache 100%
• Memantine 100%
• Randomized Crossover Clinical Trial 100%
• Placebo 50%
• Headache 25%
• N-methyl-D-aspartate Receptor Antagonist 25%
• Pathophysiology 12%
• Pain Reduction 12%
• Placebo-controlled 12%
• Beneficial Effects 12%
• Washout Period 12%
• Randomized Double-blind 12%
• Dizziness 12%
• Nausea 12%
• Verbal Rating Scale 12%
• Headache Intensity 12%
• Prophylactic Treatment 12%
• Patient-completed 12%
• High Efficacy 12%
• Chronic Pain Disorder 12%
• Pain Intensity 12%
• Variable Area 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Trial 100%
• Chronic Tension Headache 100%
• Memantine 100%
• Placebo 62%
• Headache 37%
• Aspartic Acid 25%
• Side Effect 12%
• Pathophysiology 12%
• Dizziness 12%
• Nausea 12%
• Psychogenic Pain 12%
• Chronic Pain 12%

Neuroscience

• Headache 100%
• Memantine 100%
• Placebo 62%
• Aspartic Acid 25%
• Psychogenic Pain 12%